Background, We have previously described the rejection of Gal(+) mouse hear
ts by mice lacking Gal alpha>(*) over bar * (1,3)Gal (Gal-/-) and demonstra
ted this to be a model of xenogeneic hyperacute rejection (HAR) which would
occur in pig-to-human/primate xenotransplantation, where Gal(+) antibody (
Ab) and complement (C') mediate HAR, To reduce the amount of Gal present we
used fucosyl transferase (H) as a transgene, H transferase competes for th
e same substrate as Gal transferase and reduces Gal expression by >90%.
Methods. Gal-/- mice received a heart graft from C57BL16 Gal(+) or H transg
enic mice and additional Gal Ab and C' provided; HAR was monitored by direc
t observation for up to 90 min, or by palpation thereafter. When grafts wer
e rejected they were examined macro- and microscopically,
Results. H transgenic mice were used as donors to Gal-/- mice; it was found
that: 1) C57BL/6 or H transgenic hearts were not rejected by Gal-/- recipi
ents within 90 min in the absence of additional Gal Ab, 2) If additional Ga
l Ab and C' were provided as fresh normal human serum (NHS), Gal(+) (C57BL1
6) grafts were rejected by Gal-/- mice in similar to 34 min, whereas H tran
sgenic hearts mostly lasted up to 17 hr, but were then rejected. The histol
ogical appearances showed features of both Arthus and Shwartzmann phenomena
. 3) Mice hyperimmunized with Gal with anti-Gal titers of > 1:20,000, rejec
ted Gal(+) grafts in 31 min; the survival was prolonged to 75 min with the
H transgenic hearts.
Conclusion. The presence of the H transgene in donor hearts transplanted to
naive Gal-/- mice delays the onset of HAR, but rejection ultimately occurs
; if the mice are hyperimmune earlier rejection occurs. The expression of t
he H transgene alone is insufficient to avoid HAR in the Gal-/- mouse model
; the presence of other transgenes and techniques will be required to give
an appropriate increase in survival of pig-to-human/primate grafts.